Dionex

Agilent this week introduced its AdvanceBio Peptide Mapping BioHPLC and ZORBAX RRHD 300-HILIC columns for the analysis of proteins, monoclonal antibodies, peptides and additional biologics.

Movers & Shakers

Premium

Brandon Ruotolo, Frank Witney, Kevin King, Ronald DePinho, John Mendelsohn, Lynda Chin

Pairings

Premium

Kevin King, Frank Witney, Douglas Clark, Glen Miller

According to Matthew Kuruc, COO of PIN member ProFact Proteomics, the network aims to help smaller firms offer complete solutions similar to those increasingly provided by large instrument vendors and to popularize non-mass spec-based proteomics workflows.

The $2.1 billion Dionex purchase fills out Thermo Fisher's chromatography portfolio, while its acquisition of Sterilin broadens its specialty laboratory product portfolio.

The completion follows EU clearance last week, and Thermo Fisher expects to complete the purchase of Dionex this week.

Revenues for the company's Analytical Technologies segment, which includes its life sciences mass spectrometry business, climbed 9 percent to $1.18 billion from $1.08 billion a year ago.

While Bruker launched its new maXis 4G mass spec and hinted at an LC/MS triple quadrupole instrument to come, most mass spec vendors offered little in the way of new machines for proteomics research, spotlighting instead workflows using their existing product lines.

New Products

Premium

Bruker, Agilent, Dionex, Waters

The deal, which is expected to close within weeks, is the latest in a series of purchases of nanoflow LC firms by large mass spec vendors including Thermo Fisher Scientific and AB Sciex.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.